Tue 24 Nov 2009 | 14:05 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For Nabi Biopharmaceuticals

Nabi Biopharmaceuticals (NABI.O) (Consolidated Issue listed on NASDAQ Global Market)

sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty · View NABI on other exchanges

As of 1:49pm EST

4.88USD

Price Change

+0.09

Percent Change

+1.82%

Analyst Recommendations

Independent Research | Broker Research

Name	Age	Since	Current Position
Kessler, Paul	54	2007	Senior Vice President - Clinical, Medical and Regulatory, Chief Medical Officer
Fahim, Raafat	55	2008	President, Chief Executive Officer, Acting Chief Financial Officer, Director
Cox, Geoffrey	65	2007	Non-Executive Chairman of the Board
Castaldi, David	69	1994	Director
Harvey, Richard	59	1992	Director
Jenckes, Linda	61	1997	Director
Sudovar, Stephen	62	2002	Director
Davis, Peter	62	2006	Director
Aryeh, Jason	40	2006	Director
Lynch, Timothy	39	2006	Director

Find out more about NABI.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.